Cargando…
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
BACKGROUND: The kinetics of circulating tumor DNA (ctDNA) release following commencement of radiotherapy or chemoradiotherapy may reflect early tumour cell killing. We hypothesised that an increase in ctDNA may be observed after the first fraction of radiotherapy and that this could have clinical si...
Autores principales: | MacManus, Michael, Kirby, Laura, Blyth, Benjamin, Banks, Owen, Martin, Olga A., Yeung, Miriam M., Plumridge, Nikki, Shaw, Mark, Hegi-Johnson, Fiona, Siva, Shankar, Ball, David, Wong, Stephen Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551836/ https://www.ncbi.nlm.nih.gov/pubmed/37808452 http://dx.doi.org/10.1016/j.ctro.2023.100682 |
Ejemplares similares
-
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases
por: Sogono, Paolo, et al.
Publicado: (2021) -
Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation
por: MacManus, Michael P, et al.
Publicado: (2014) -
Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
por: Deng, Wei, et al.
Publicado: (2020) -
A Pattern of Early Radiation-Induced Inflammatory Cytokine Expression Is Associated with Lung Toxicity in Patients with Non-Small Cell Lung Cancer
por: Siva, Shankar, et al.
Publicado: (2014) -
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with (89)Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol
por: Hegi-Johnson, Fiona, et al.
Publicado: (2022)